Intramuscular pentazocine versus diclofenac suppository and intramuscular pentazocine for postcaesarean section pain relief-A double blind RCT

Intramuscular pentazocine versus diclofenac suppository and intramuscular pentazocine for postcaesarean section pain relief-A double blind randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201508001159254

Enrollment

136

Registered

2015-06-03

Start date

2015-06-10

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Postcaesarean pain

Interventions

Diclofenac suppository

Placebo suppository

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA (American Society of Anesthesiologists¿ Classification) 1 and II status Elective and emergency low segment caesarean section Spinal anaesthesia

Exclusion criteria

Exclusion criteria: Refusal to participate in the study Epigastic pain Known peptic ulcer Bleeding problem, excessive intraoperative blood loss (>1000mls) Previous history of hypersensitivity reaction to NSAIDS, pentazocine, tramadoL Excessive perioperative blood loss (>1000mls).

Design outcomes

Primary

Measure	Time frame
To compare the efficacy, side effects, and level of satisfaction of intramuscular pentazocine alone with combination of diclofenac suppository and intramuscular pentazocine.	—

Countries

Nigeria

Contacts

Public ContactSimeon Olateju

Lecturer/Consultant/Obafemi Awolowo University

gbadeteju2005@yahoo.com+2348033885482

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026